[38] Medved, I., Brown, M.J., Bjorksten, A.R., Murphy, K.T., Petersen, A.C., Sostaric, S
View Study [4]"Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wasting" Levolger S, Wiemer EAC, et al., 2019 Finding: LR3 IGF-I treatment effectively limited muscle mass loss in a cancer cachexia model, demonstrating its potent anti-catabolic effects and ability to preserve muscle tissue under conditions that normally cause severe muscle wasting
IARC Monogr Eval Carcinog Risks Hum
Furthermore, leaf metabolism seems to be very different from root metabolism
PTGS2, Prostaglandin-Endoperoxide Synthase 2